CAR-TCR Summit

Memo

As the commercialization and approval of CAR-T therapies continues to gain momentum, the leaders are working to globalize the delivery of "curative" CAR-T and TCR therapies to beyond the Western world. Asia, as one of the world’s largest economies will serve as a cornerstone for the development and delivery of novel cellular immunotherapies.



The CAR-TCR Summit Asia is the dedicated platform focused on ensuring the clinical translation of CAR-T and TCR therapies to the market globally, ensuring affordability and accessibility to all those in need.



Join the leaders in therapeutic drug development as they discuss the latest clinical data emerging in Asia, focussing on the affects of ethnicity on safety and efficacy.

Discover the novel targets beyond CD19 being utilized for solid tumor indications.

Discuss the next generation technologies being used to automate manufacturing and reduce the CoGs to increase the affordability of CAR-TCR therapies worldwide.



URLs:

Tickets: https://go.evvnt.com/204424-1?pid=5569

Brochure: https://go.evvnt.com/204424-2?pid=5569



Price

Standard Pricing (International): USD 2599

Standard Pricing (China): USD 1999

Drug Developer Pricing (International): USD 2299

Drug Developer Pricing (China): USD 999



Speakers: Zonghai Li, Jennifer Chow, Tony Liu, Mark Sawicki, Richard Wang, Philip Vanek, Sicco Popma, Ting He, Lei Xiao, Paul Dai, Ian Johnston, Frank Fan, Pascal Touchon, Jim Freeth, Henry Ji, Peter Sun, John Connolly, Yangbing Zhao



Wednesday June 27, 2018 at 9:00 am (ends Thursday June 28, 2018 at 5:00 pm)



Venue details

Four Points By Sheraton Singapore

382 Havelock Road, Singapore 169629, Singapore